News

Understand the health implications of cat vomit phlegm and find practical solutions. A comprehensive guide to help you care for your cat's health.
Itepekimab met the primary endpoint in one of two COPD phase 3 studies AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former ...
Panelists discuss how belumosudil is particularly effective for patients with lung involvement due to its antifibrotic mechanism.
I was in Chicago this weekend attending the ASCO meeting, the largest oncology meeting in the world. Nary a talk or poster ...
Discover surprising risk factors for type 2 diabetes beyond diet and weight. Learn about hidden triggers that could increase ...
Sanofi & Regeneron announce itepekimab meet the primary endpoint in one of two COPD phase 3 studies: Paris Saturday, May 31, 2025, 10:00 Hrs [IST] The AERIFY-1 phase 3 study evalu ...
Cat pooping and vomiting can be alarming. Find out the causes and solutions to help your cat recover with our comprehensive guide.
AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided a clinically me ...
AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers rega ...
Detailed price information for Cartesian Therapeutics Inc (RNAC-Q) from The Globe and Mail including charting and trades.
About itepekimab Itepekimab is a fully human monoclonal antibody that binds to and inhibits interleukin-33 (IL33), an initiator and amplifier of broad inflammation in COPD. IL33 is thought to be ...